Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


AMG 595, an Anti-EGFRvIII Antibody-Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma.

Hamblett KJ, Kozlosky CJ, Siu S, Chang WS, Liu H, Foltz IN, Trueblood ES, Meininger D, Arora T, Twomey B, Vonderfecht SL, Chen Q, Hill JS, Fanslow WC.

Mol Cancer Ther. 2015 Jul;14(7):1614-24. doi: 10.1158/1535-7163.MCT-14-1078. Epub 2015 Apr 30.


Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.

Stepan LP, Trueblood ES, Hale K, Babcook J, Borges L, Sutherland CL.

J Histochem Cytochem. 2011 Jul;59(7):701-10. doi: 10.1369/0022155411410430. Epub 2011 May 6.


IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.

Blumberg H, Dinh H, Dean C Jr, Trueblood ES, Bailey K, Shows D, Bhagavathula N, Aslam MN, Varani J, Towne JE, Sims JE.

J Immunol. 2010 Oct 1;185(7):4354-62. doi: 10.4049/jimmunol.1000313. Epub 2010 Sep 10.


Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis.

Mozaffarian A, Brewer AW, Trueblood ES, Luzina IG, Todd NW, Atamas SP, Arnett HA.

J Immunol. 2008 Nov 15;181(10):7243-53.


Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, Peschon JJ.

J Exp Med. 2007 Oct 29;204(11):2603-14. Epub 2007 Oct 1.


B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2.

Trueblood ES, Brown WC, Palmer GH, Davis WC, Stone DM, McElwain TF.

J Virol. 1998 Apr;72(4):3169-77.


Canine fatalities associated with the use of a modified live vaccine administered during late stages of pregnancy.

Evermann JF, McKeirnan AJ, Wilbur LA, Levings RL, Trueblood ES, Baldwin TJ, Hughbanks FG.

J Vet Diagn Invest. 1994 Jul;6(3):353-7. No abstract available.


Supplemental Content

Loading ...
Support Center